RxDoctor Payments DataLook up a doctor →

IWILFIN: payments to doctors

Payments that named IWILFIN as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$273K
Providers
318
Transactions
505
Average per transaction
$540

The per-transaction average — $540 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 318 providers the average total is $858, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
USWM, LLC$199,16073.0%
HEMA Biologics, LLC$73,66427.0%
← All drugs & devices